Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced or Metastatic HER2-Expressing Cancers

Explore clinical trials studying Locally Advanced or Metastatic HER2-Expressing Cancers. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Locally Advanced or Metastatic HER2-Expressing Cancers trial results

Recruiting

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

NCT05356741

Conditions
Locally Advanced or Metastatic HER2-Expressing Cancers
Locations
  • Investigational site number #100 Melbourne, Victoria, Australia
  • Investigational site number #101 Randwick, Australia
  • Investigational site number #150 Toulouse, France
  • Investigational site number #200 Porto, Portugal
View Trial Details